769131-04-6

Basic information

• Product Name: 4-[(3,5-bis-trifluoromethylphenyl)-hydroxy-methyl]-2-ethyl-6-trifluoromethyl-2H-quinoline-1-carboxylic acid ethyl ester
• Synonyms: 4-[(3,5-bis-trifluoromethylphenyl)-hydroxy-methyl]-2-ethyl-6-trifluoromethyl-2H-quinoline-1-carboxylic acid ethyl ester
• CAS NO: 769131-04-6
• Molecular Weight: 541.413
• Mol File: 769131-04-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-[(3,5-bis-trifluoromethylphenyl)-hydroxy-methyl]-2-ethyl-6-trifluoromethyl-2H-quinoline-1-carboxylic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[(3,5-bis-trifluoromethylphenyl)-hydroxy-methyl]-2-ethyl-6-trifluoromethyl-2H-quinoline-1-carboxylic acid ethyl ester(769131-04-6)
• EPA Substance Registry System: 4-[(3,5-bis-trifluoromethylphenyl)-hydroxy-methyl]-2-ethyl-6-trifluoromethyl-2H-quinoline-1-carboxylic acid ethyl ester(769131-04-6)

Safety Data

• Hazardous Substances Data: 769131-04-6(Hazardous Substances Data)

Upstream product

• 401-95-6 3,5-Bis(trifluoromethyl)benzaldehyde 

Relevant articles and documents

1,2,4-SUBSTITUERTE 1,2,3,4-TETRAHYDRO-AND 1,2 DIHYDRO-QUINOLINE AND 1,2,3,4-TETRAHYDRO-QUINOXALINE DERIVATIVES AS CETP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROSIS AND OBESITY

Quinoline and quinoxaline compounds of formula I and III wherein the subtituent are as defined in claims 1 and 15, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.